paper-with-me

Papers

Structure-based inhibitor screening of natural products against NSP15 of SARS- CoV-2 revealed Thymopentin and Oleuropein as potent inhibitors

2020-07-28 · Ramachandran Vijayan, Samudrala Gourinath

Coronaviruses are enveloped, non-segmented positive-sense RNA viruses that have the largest genome among RNA viruses. The genome contains a large replicase ORF encodes nonstructural proteins (NSPs), structural and accessory genes. NSP15 is a nidoviral RNA uridylate-specific endoribonuclease (NendoU) has C-terminal catalytic domain. The endoribonuclease activity of NSP15 interferes with the innate immune response of the host. Here, we screened Selleckchem Natural product database of compounds against the NSP15, Thymopentin and Oleuropein showed highest binding energies. The binding of these molecules was further validated by Molecular dynamic simulation and found very stable complexes. These drugs might serve as effective counter molecules in the reduction of virulence of this virus. Future validation of both these inhibitors are worth consideration for patients being treated for COVID -19.

📄 PDF Abstract BibTeX arXiv:2007.14375

Code (0)

등록된 구현이 없습니다.

Similar Papers 제목 키워드 기반

Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies

2020-11-29 · Sakshi Piplani, Puneet Singh, David A. Winkler, Nikolai Petrovsky

For fast development of COVID-19, it is only feasible to use drugs (off label use) or approved natural products that are already registered or been assessed for safety in previous human trials. These agents can be quickl…

In silico Identification of tipifarnib-like compounds by structure-based pharmacophore, virtual screening and molecular docking against K-Ras post-translation in colorectal cancer

2023-05-07 · Mohammed Mouhcine, Youness Kadil1, Imane Rahmoune, Houda Filali

Colorectal cancer is a public health problem.Approximately 30 to 50 \% of colorectal tumors are caused by mutations in the KRAS gene.These mutations induce uncontrolled proliferation.To date,There is no approved effectiv…

Molecular Docking

In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection

2020-06-01 · R. P. Vivek-Ananth, Abhijit Rana, Nithin Rajan, Himansu S. Biswal 외

Presently, there are no approved drugs or vaccines to treat COVID-19 which has spread to over 200 countries and is responsible for over 3,65,000 deaths worldwide. Recent studies have shown that two human proteases, TMPRS…

Molecular DockingSpecificity

The natural polyphenol fortunellin and its structural analogs are inhibitors of the SARS-CoV-2 main proteinase dimerization, as revealed by molecular simulation studies

2020-07-15 · Athanasios A. Panagiotopoulos, Danai-Maria Kotzampasi, George Sourvinos, Marilena Kampa 외

3CL-Pro (or M-Pro) is the SARS-CoV-2 main protease, acting as a homodimer, is responsible for the cleavage of the large polyprotein 1ab transcript in proteins acting on viral growth and replication. 3CL-Pro has been one …

In Silico Prediction and Validation of LmGt Inhibitors Using QSAR and Molecular Docking Approaches

2025-05-12 · Pronama Biswas, Madhavi Bhatt, Belaguppa Manjunath Ashwin Desai

Leishmaniasis caused by Leishmania mexicana relies on Leishmania mexicana gluscose transporter (LmGT) receptors, which play an important role in glucose and ribose uptake at different stages of parasite's life cycle. Pre…

Drug DiscoveryMolecular DockingSpecificity